Hi-Risk/Recurrent/Advanced PCa Video Chat, Jan 20, 2025

by | Jan 22, 2025 | Cancer Resources, High Risk/Recurrent/Advanced, High Risk/Recurrent/Advanced Prostate Cancer, mCRPC, mHSPC, nmCRPC, Prostate Cancer, Recorded Groups

Intermediate Risk Prostate Cancer Graphic

Hi-Risk/Recurrent/Advanced PCa Video Chat, Jan 20, 2025

Watching this-  made a donation yet? If not, now’s the time – PLEASE! It’s AnCan’s Annual Fundraiser – once a year is the only time we ask for donations.
We’ve received less than 10% from participants, viewers and those receiving the Reminder combined. Time to step up and show appreciation and gratitude if you watch these videos, find them helpful., and want them to continue. Donate now at https://ancan.org/donate/
IF YOU’RE WATCHING THIS VIDEO, PLEASE COMPLETE OUR SHORT, 7-MINUTE ANCAN 2024 SURVEY...  https://docs.google.com/forms/d/e/1FAIpQLSfw2B3rZTMWIPqTmzLYBl1CdN9qRJSpt0f72CoK6J00zllzWw/viewform  AnCan needs your feedback and we also hope to take the results to medical conferences. We will be closing out in the next couple of weeks, so no more procrastinating please!! Analysis is scheduled to start soon and we are at 454 response in total. Let’s break 500!
AnCan is grateful to the following sponsors for making this recording possible: Bayer, Foundation Medicine, Janssen, Myriad Genetics, Novartis, Telix & Blue Earth Diagnostic.
If you missed any recent recordings, you’ll find a full list either on our YouTube Playlist or visit our Blog Post https://ancan.org/our-recent-blog-posts-in-case-you-missed-them/   Sign up for our Blog by checking the New Blog box at https://ancan.org/contact-us/
AnCan respectfully notes that it does not accept sponsored promotion. Any drugs, protocols or devices recommended in our discussions are based solely on anecdotal peer experience or clinical evidence.
AnCan cannot and does not provide medical advice. We encourage you to discuss anything you hear in our sessions with your own medical team.
AnCan reminds all Participants that Adverse Events experienced from prescribed drugs or protocols should be reported to the pharmaceutical manufacturer or the FDA Adverse Event Reporting System (FAERS). To do so call 1-800-332-1066 or download interactive FDA Form 3500 https://www.fda.gov/media/76299/download
All AnCan’s groups are free and drop-in … join us in person sometime!
Join our other free and drop in groups:

Editor’s Pick: Always a challenge to know when to resume treatment – 2 gents raise the issue (rd)

Topics Discussed

Decipher report causes unnecessary concern for Newbie with recurrence; lurker becomes Newbie – E2 doing the job but what about RT?; PSA doubles from low levels – test more frequently; great news… scans seem to show FDG and PSMA concordance; zero ctDNA measured in trial and nothing actionable; Dr. E monitors for other cancers with MUTYH driver; why no doublet for this Gent? sounds like GU MO waffle; PSMA suggests it’s time to debulk w. RT and maybe go wider; another example of undertreatment of Mx disease; does RT and ADT effect bone integrity – esp. hips?; PSA rise may be test error with 3 decimal places – don’t jump the gun!

Chat Log

  • AnCan – rick sent: 6:18 PM

    Survey https://docs.google.com/forms/d/e/1FAIpQLSfw2B3rZTMWIPqTmzLYBl1CdN9qRJSpt0f72CoK6J00zllzWw/viewform

  • John A sent: 6:22 PM

    I wouldn’t mind a look at that report

  • Eric M- Atlanta sent: 6:39 PM

    If anyone is curious: Decipher GRID-Derived Gene Expression Signature Can Help Personalize Prostate Cancer Treatment https://investor.veracyte.com/news-releases/news-release-details/new-data-be-presented-2023-asco-gu-suggest-decipher-grid-derived

    Lostsheep I believe

  • Larry Schuller sent: 7:03 PM

    Franktalk.org

    Larry Schuller email is ( contact rd@ancan.org for email) if anyone has questions about my research, implants, anything

  • Eric M- Atlanta sent: 7:14 PM

    Have to bounce. Have a good evening all.

  • Julian sent: 7:43 PM

    Have to go – Great conversations as always!!!